NCT00033202View on ClinicalTrials.gov

This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Solid Tumor

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2002

Study Completion Date

February 28, 2005

Conditions
Solid Malignancies
Interventions
DRUG

Gimatecan® (ST-1481)

Trial Locations (3)

02114

Massachusetts General Hospital, Boston

02115

Dana-Farber Cancer Institute, Boston

02903

Rhode Island Hospital, Providence

All Listed Sponsors
collaborator

Rhode Island Hospital

OTHER

collaborator

Dana-Farber Cancer Institute

OTHER

lead

Sigma-Tau Research, Inc.

INDUSTRY

NCT00033202 - This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Solid Tumor | Biotech Hunter | Biotech Hunter